| Symbol |
Name |
Standardized Value |
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
4.0
|
|
IL1B
|
interleukin 1, beta
|
4.0
|
|
TNF
|
tumor necrosis factor
|
4.0
|
|
JUN
|
jun proto-oncogene
|
4.0
|
|
IFNG
|
interferon, gamma
|
4.0
|
|
TP53
|
tumor protein p53
|
4.0
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
4.0
|
|
TGFB1
|
transforming growth factor, beta 1
|
4.0
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
4.0
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
4.0
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
4.0
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
4.0
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
4.0
|
|
IL6
|
interleukin 6
|
4.0
|
|
TLR4
|
toll-like receptor 4
|
4.0
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
4.0
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
4.0
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
4.0
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
4.0
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
3.993
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
3.983
|
|
ESR1
|
estrogen receptor 1
|
3.95
|
|
INS
|
insulin
|
3.949
|
|
CD4
|
CD4 molecule
|
3.937
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
3.933
|
|
IL10
|
interleukin 10
|
3.931
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
3.922
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
3.892
|
|
CCND1
|
cyclin D1
|
3.886
|
|
CD8A
|
CD8a molecule
|
3.871
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
3.841
|
|
EGFR
|
epidermal growth factor receptor
|
3.841
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
3.837
|
|
H3-5
|
H3.5 histone
|
3.834
|
|
H3-4
|
H3.4 histone, cluster member
|
3.834
|
|
H3-7
|
H3.7 histone (putative)
|
3.833
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
3.826
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
3.822
|
|
IL1A
|
interleukin 1, alpha
|
3.792
|
|
MYD88
|
myeloid differentiation primary response 88
|
3.791
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
3.789
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
3.764
|
|
HMOX1
|
heme oxygenase 1
|
3.761
|
|
MMP9
|
matrix metallopeptidase 9
|
3.752
|
|
CREB1
|
cAMP responsive element binding protein 1
|
3.729
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
3.728
|
|
PTEN
|
phosphatase and tensin homolog
|
3.725
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
3.723
|
|
EGF
|
epidermal growth factor
|
3.718
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
3.716
|
|
IL4
|
interleukin 4
|
3.707
|
|
ANXA5
|
annexin A5
|
3.706
|
|
IL2
|
interleukin 2
|
3.7
|
|
PCNA
|
proliferating cell nuclear antigen
|
3.697
|
|
SIRT1
|
sirtuin 1
|
3.697
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
3.686
|
|
BAX
|
BCL2-associated X protein
|
3.682
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
3.679
|
|
ATM
|
ATM serine/threonine kinase
|
3.673
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
3.671
|
|
TLR2
|
toll-like receptor 2
|
3.665
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
3.664
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
3.642
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
3.63
|
|
ICAM1
|
intercellular adhesion molecule 1
|
3.629
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
3.628
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
3.616
|
|
BRCA1
|
breast cancer 1, early onset
|
3.615
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
3.612
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
3.603
|
|
PGR
|
progesterone receptor
|
3.597
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
3.596
|
|
HDAC9
|
histone deacetylase 9
|
3.594
|
|
CD34
|
CD34 molecule
|
3.586
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
3.586
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
3.583
|
|
IRF3
|
interferon regulatory factor 3
|
3.582
|
|
CD274
|
CD274 molecule
|
3.58
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
3.577
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
3.572
|
|
JAK2
|
Janus kinase 2
|
3.568
|
|
LEP
|
leptin
|
3.568
|
|
SMAD2
|
SMAD family member 2
|
3.567
|
|
IFNA1
|
interferon, alpha 1
|
3.562
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
3.559
|
|
SMAD4
|
SMAD family member 4
|
3.558
|
|
BCL2L1
|
BCL2-like 1
|
3.556
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
3.554
|
|
SMAD3
|
SMAD family member 3
|
3.552
|
|
FN1
|
fibronectin 1
|
3.54
|
|
CD44
|
CD44 molecule (Indian blood group)
|
3.54
|
|
IL18
|
interleukin 18
|
3.536
|
|
EP300
|
E1A binding protein p300
|
3.535
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
3.531
|
|
POU5F1
|
POU class 5 homeobox 1
|
3.529
|
|
FOXO1
|
forkhead box O1
|
3.525
|
|
FOXP3
|
forkhead box P3
|
3.523
|
|
H2BC21
|
H2B clustered histone 21
|
3.52
|
|
POMC
|
proopiomelanocortin
|
3.519
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
3.516
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
3.513
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
3.512
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
3.51
|
|
HDAC1
|
histone deacetylase 1
|
3.496
|
|
RUNX2
|
runt-related transcription factor 2
|
3.496
|
|
CYCS
|
cytochrome c, somatic
|
3.496
|
|
CDPF1
|
cysteine-rich, DPF motif domain containing 1
|
3.485
|
|
DICER1
|
dicer 1, ribonuclease type III
|
3.485
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
3.482
|
|
CDK4
|
cyclin-dependent kinase 4
|
3.482
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
3.481
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
3.476
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
3.474
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
3.474
|
|
BDNF
|
brain-derived neurotrophic factor
|
3.473
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
3.47
|
|
NANOG
|
Nanog homeobox
|
3.467
|
|
CD68
|
CD68 molecule
|
3.467
|
|
LMNB1
|
lamin B1
|
3.464
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
3.46
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
3.458
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
3.458
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
3.456
|
|
MMP2
|
matrix metallopeptidase 2
|
3.448
|
|
HSPA4
|
heat shock 70kDa protein 4
|
3.448
|
|
SNAI1
|
snail family zinc finger 1
|
3.446
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
3.446
|
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|
3.445
|
|
FOXO3
|
forkhead box O3
|
3.442
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
3.44
|
|
TLR3
|
toll-like receptor 3
|
3.44
|
|
CDK2
|
cyclin-dependent kinase 2
|
3.439
|
|
NOTCH1
|
notch 1
|
3.436
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
3.435
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
3.432
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
3.431
|
|
IL13
|
interleukin 13
|
3.428
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
3.426
|
|
GFAP
|
glial fibrillary acidic protein
|
3.426
|
|
DNTT
|
DNA nucleotidylexotransferase
|
3.422
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
3.414
|
|
DROSHA
|
drosha, ribonuclease type III
|
3.413
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
3.411
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
3.408
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
3.406
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
3.406
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
3.405
|
|
HMGB1
|
high mobility group box 1
|
3.403
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
3.392
|
|
CDK1
|
cyclin-dependent kinase 1
|
3.392
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
3.391
|
|
RIGI
|
RNA sensor RIG-I
|
3.383
|
|
MPO
|
myeloperoxidase
|
3.382
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
3.38
|
|
BRCA2
|
breast cancer 2, early onset
|
3.379
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
3.377
|
|
RUNX1
|
runt-related transcription factor 1
|
3.375
|
|
NPY
|
neuropeptide Y
|
3.374
|
|
JAK1
|
Janus kinase 1
|
3.373
|
|
CCNL2
|
cyclin L2
|
3.373
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
3.372
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
3.37
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
3.37
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
3.37
|
|
H2AC20
|
H2A clustered histone 20
|
3.37
|
|
E2F1
|
E2F transcription factor 1
|
3.367
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
3.366
|
|
APOE
|
apolipoprotein E
|
3.364
|
|
AHR
|
aryl hydrocarbon receptor
|
3.363
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
3.36
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
3.357
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
3.355
|
|
CD19
|
CD19 molecule
|
3.353
|
|
AIF1
|
allograft inflammatory factor 1
|
3.351
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
3.351
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
3.351
|
|
LGALS4
|
lectin, galactoside-binding, soluble, 4
|
3.351
|
|
TLR9
|
toll-like receptor 9
|
3.35
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
3.349
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
3.349
|
|
EGR1
|
early growth response 1
|
3.34
|
|
RAD51
|
RAD51 recombinase
|
3.34
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
3.335
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
3.335
|
|
CD86
|
CD86 molecule
|
3.334
|
|
XPO1
|
exportin 1
|
3.331
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
3.331
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
3.331
|
|
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1
|
3.329
|
|
TERT
|
telomerase reverse transcriptase
|
3.325
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
3.319
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
3.318
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
3.316
|
|
TBP
|
TATA box binding protein
|
3.316
|
|
GPX3
|
glutathione peroxidase 3
|
3.315
|
|
AXIN1
|
axin 1
|
3.314
|
|
GPX2
|
glutathione peroxidase 2
|
3.314
|
|
GCG
|
glucagon
|
3.313
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
3.312
|
|
CHEK1
|
checkpoint kinase 1
|
3.312
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
3.308
|
|
HDAC2
|
histone deacetylase 2
|
3.307
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
3.306
|
|
RARA
|
retinoic acid receptor, alpha
|
3.304
|
|
GATA3
|
GATA binding protein 3
|
3.304
|
|
CCNA2
|
cyclin A2
|
3.303
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
3.303
|
|
CCNB1
|
cyclin B1
|
3.302
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
3.3
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
3.299
|
|
TLR7
|
toll-like receptor 7
|
3.299
|
|
RHOA
|
ras homolog family member A
|
3.297
|
|
H2AX
|
H2A.X variant histone
|
3.293
|
|
GPX7
|
glutathione peroxidase 7
|
3.292
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
3.29
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
3.287
|
|
GPX5
|
glutathione peroxidase 5
|
3.287
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
3.287
|
|
GPX6
|
glutathione peroxidase 6
|
3.286
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
3.284
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
3.28
|
|
KDR
|
kinase insert domain receptor
|
3.28
|
|
APP
|
amyloid beta (A4) precursor protein
|
3.277
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
3.276
|
|
HDAC3
|
histone deacetylase 3
|
3.276
|
|
IRF1
|
interferon regulatory factor 1
|
3.276
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
3.274
|
|
NCAM1
|
neural cell adhesion molecule 1
|
3.273
|
|
IRF7
|
interferon regulatory factor 7
|
3.273
|
|
CD28
|
CD28 molecule
|
3.271
|
|
SHH
|
sonic hedgehog
|
3.27
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
3.27
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
3.265
|
|
LMNA
|
lamin A/C
|
3.265
|
|
TJP1
|
tight junction protein 1
|
3.265
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
3.264
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
3.258
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
3.257
|
|
CREBBP
|
CREB binding protein
|
3.256
|
|
CD80
|
CD80 molecule
|
3.254
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
3.252
|
|
ACE
|
angiotensin I converting enzyme
|
3.252
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
3.252
|
|
CRH
|
corticotropin releasing hormone
|
3.251
|
|
GLB1
|
galactosidase, beta 1
|
3.25
|
|
TBK1
|
TANK-binding kinase 1
|
3.25
|
|
FGF7
|
fibroblast growth factor 7
|
3.25
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
3.25
|
|
GATA4
|
GATA binding protein 4
|
3.25
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
3.249
|
|
IL5
|
interleukin 5
|
3.249
|
|
CCN2
|
cellular communication network factor 2
|
3.249
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
3.243
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
3.242
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
3.241
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
3.239
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
3.239
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
3.237
|
|
MCL1
|
myeloid cell leukemia 1
|
3.236
|
|
FGF10
|
fibroblast growth factor 10
|
3.236
|
|
TCHP
|
trichoplein, keratin filament binding
|
3.235
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
3.235
|
|
MMP3
|
matrix metallopeptidase 3
|
3.233
|
|
FGF4
|
fibroblast growth factor 4
|
3.233
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
3.232
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
3.229
|
|
YAP1
|
Yes-associated protein 1
|
3.228
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
3.227
|
|
LOC124905743
|
low affinity immunoglobulin gamma Fc region receptor III-B
|
3.227
|
|
MLH1
|
mutL homolog 1
|
3.225
|
|
BECN1
|
beclin 1, autophagy related
|
3.222
|
|
MYOD1
|
myogenic differentiation 1
|
3.221
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
3.22
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
3.22
|
|
NES
|
nestin
|
3.22
|
|
MRC1
|
mannose receptor, C type 1
|
3.219
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
3.219
|
|
AGRP
|
agouti related neuropeptide
|
3.218
|
|
SPI1
|
Spi-1 proto-oncogene
|
3.216
|
|
INSR
|
insulin receptor
|
3.214
|
|
LSM2
|
LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae)
|
3.214
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
3.214
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
3.212
|
|
SCARB1
|
scavenger receptor class B, member 1
|
3.212
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
3.211
|
|
SNAI2
|
snail family zinc finger 2
|
3.21
|
|
FGF9
|
fibroblast growth factor 9
|
3.21
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
3.207
|
|
CCNA1
|
cyclin A1
|
3.206
|
|
SST
|
somatostatin
|
3.206
|
|
CALML3
|
calmodulin-like 3
|
3.203
|
|
CALML5
|
calmodulin-like 5
|
3.202
|
|
FGF5
|
fibroblast growth factor 5
|
3.202
|
|
CALML4
|
calmodulin-like 4
|
3.201
|
|
CALML6
|
calmodulin-like 6
|
3.2
|
|
WT1
|
Wilms tumor 1
|
3.2
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
3.2
|
|
CDK6
|
cyclin-dependent kinase 6
|
3.199
|
|
IL1R1
|
interleukin 1 receptor, type I
|
3.199
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
3.198
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
3.198
|
|
FLT3
|
fms-related tyrosine kinase 3
|
3.198
|
|
AGO2
|
argonaute RISC catalytic component 2
|
3.196
|
|
FGF3
|
fibroblast growth factor 3
|
3.195
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
3.193
|
|
FGF18
|
fibroblast growth factor 18
|
3.193
|
|
LOX
|
lysyl oxidase
|
3.192
|
|
BRD4
|
bromodomain containing 4
|
3.191
|
|
YY1
|
YY1 transcription factor
|
3.19
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
3.19
|
|
FGF17
|
fibroblast growth factor 17
|
3.188
|
|
NCOR1
|
nuclear receptor corepressor 1
|
3.188
|
|
EPCAM
|
epithelial cell adhesion molecule
|
3.187
|
|
ACE2
|
angiotensin I converting enzyme 2
|
3.187
|
|
PROM1
|
prominin 1
|
3.187
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
3.186
|
|
NF1
|
neurofibromin 1
|
3.186
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
3.185
|
|
SYP
|
synaptophysin
|
3.184
|
|
FGF20
|
fibroblast growth factor 20
|
3.183
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
3.182
|
|
MSH6
|
mutS homolog 6
|
3.181
|
|
TH
|
tyrosine hydroxylase
|
3.178
|
|
FGF6
|
fibroblast growth factor 6
|
3.178
|
|
IRS1
|
insulin receptor substrate 1
|
3.178
|
|
SELE
|
selectin E
|
3.178
|
|
FGF16
|
fibroblast growth factor 16
|
3.177
|
|
MMP13
|
matrix metallopeptidase 13
|
3.177
|
|
PDCD1
|
programmed cell death 1
|
3.175
|
|
TARDBP
|
TAR DNA binding protein
|
3.174
|
|
EPAS1
|
endothelial PAS domain protein 1
|
3.173
|
|
FGF22
|
fibroblast growth factor 22
|
3.173
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
3.172
|
|
H4C7
|
H4 clustered histone 7
|
3.172
|
|
EDN1
|
endothelin 1
|
3.171
|
|
BMP4
|
bone morphogenetic protein 4
|
3.169
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
3.169
|
|
JUND
|
jun D proto-oncogene
|
3.169
|
|
KRT7
|
keratin 7, type II
|
3.167
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
3.167
|
|
MSH2
|
mutS homolog 2
|
3.167
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
3.166
|
|
MMUT
|
methylmalonyl-CoA mutase
|
3.166
|
|
IL33
|
interleukin 33
|
3.165
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
3.159
|
|
SCARB2
|
scavenger receptor class B, member 2
|
3.158
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
3.158
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
3.157
|
|
HNRNPDL
|
heterogeneous nuclear ribonucleoprotein D-like
|
3.157
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
3.156
|
|
XPO5
|
exportin 5
|
3.155
|
|
GLI1
|
GLI family zinc finger 1
|
3.155
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
3.154
|
|
THY1
|
Thy-1 cell surface antigen
|
3.153
|
|
BMP2
|
bone morphogenetic protein 2
|
3.151
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
3.15
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
3.15
|
|
BMAL1
|
basic helix-loop-helix ARNT like 1
|
3.149
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
3.147
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
3.146
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
3.146
|
|
XPR1
|
xenotropic and polytropic retrovirus receptor 1
|
3.146
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
3.146
|
|
SMAD7
|
SMAD family member 7
|
3.145
|
|
PKM
|
pyruvate kinase, muscle
|
3.144
|
|
IL3
|
interleukin 3
|
3.144
|
|
COL1A1
|
collagen, type I, alpha 1
|
3.141
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
3.139
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
3.138
|
|
IL22
|
interleukin 22
|
3.137
|
|
CD40LG
|
CD40 ligand
|
3.135
|
|
IGF2
|
insulin-like growth factor 2
|
3.133
|
|
JAG1
|
jagged 1
|
3.132
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
3.129
|
|
FOXM1
|
forkhead box M1
|
3.128
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
3.128
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
3.126
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
3.126
|
|
IRF4
|
interferon regulatory factor 4
|
3.125
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
3.124
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
3.123
|
|
OCLN
|
occludin
|
3.123
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
3.122
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
3.121
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
3.12
|
|
AXIN2
|
axin 2
|
3.12
|
|
CD163
|
CD163 molecule
|
3.12
|
|
FUS
|
FUS RNA binding protein
|
3.119
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
3.119
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
3.117
|
|
TRAF3
|
TNF receptor-associated factor 3
|
3.116
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
3.115
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
3.115
|
|
SOD1
|
superoxide dismutase 1, soluble
|
3.114
|
|
POTEF
|
POTE ankyrin domain family, member F
|
3.114
|
|
FOSL1
|
FOS-like antigen 1
|
3.113
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
3.112
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
3.111
|
|
BCR
|
breakpoint cluster region
|
3.109
|
|
CDX2
|
caudal type homeobox 2
|
3.109
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
3.108
|
|
PAX6
|
paired box 6
|
3.105
|
|
H1-0
|
H1.0 linker histone
|
3.105
|
|
CTSK
|
cathepsin K
|
3.104
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
3.103
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
3.103
|
|
SYK
|
spleen tyrosine kinase
|
3.103
|
|
XBP1
|
X-box binding protein 1
|
3.102
|
|
TYK2
|
tyrosine kinase 2
|
3.102
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
3.102
|
|
IL7
|
interleukin 7
|
3.102
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
3.101
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
3.1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
3.099
|
|
PIWIL4
|
piwi-like RNA-mediated gene silencing 4
|
3.099
|
|
IL15
|
interleukin 15
|
3.098
|
|
CDC42
|
cell division cycle 42
|
3.097
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
3.097
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
3.097
|
|
KRT5
|
keratin 5, type II
|
3.094
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
3.094
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
3.094
|
|
CDK9
|
cyclin-dependent kinase 9
|
3.094
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
3.092
|
|
TAC1
|
tachykinin, precursor 1
|
3.09
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
3.09
|
|
TBX21
|
T-box 21
|
3.09
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
3.09
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
3.088
|
|
SIRT2
|
sirtuin 2
|
3.087
|
|
CD38
|
CD38 molecule
|
3.086
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
3.086
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
3.082
|
|
ATF3
|
activating transcription factor 3
|
3.082
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
3.081
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
3.08
|
|
CGAS
|
cyclic GMP-AMP synthase
|
3.078
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
3.077
|
|
FGF13
|
fibroblast growth factor 13
|
3.077
|
|
MYOG
|
myogenin (myogenic factor 4)
|
3.076
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
3.075
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
3.075
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
3.073
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
3.072
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
3.072
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
3.071
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
3.071
|
|
SQSTM1
|
sequestosome 1
|
3.071
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
3.069
|
|
HNF1A
|
HNF1 homeobox A
|
3.069
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
3.067
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
3.067
|
|
LATS1
|
large tumor suppressor kinase 1
|
3.067
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
3.067
|
|
STK11
|
serine/threonine kinase 11
|
3.064
|
|
B2M
|
beta-2-microglobulin
|
3.064
|
|
PRL
|
prolactin
|
3.063
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
3.062
|
|
ATF6
|
activating transcription factor 6
|
3.061
|
|
IRF9
|
interferon regulatory factor 9
|
3.06
|
|
HDAC4
|
histone deacetylase 4
|
3.059
|
|
PLK1
|
polo-like kinase 1
|
3.059
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
3.058
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
3.058
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
3.057
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
3.055
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
3.053
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
3.051
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
3.051
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
3.051
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
3.05
|
|
PAX5
|
paired box 5
|
3.05
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
3.05
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
3.049
|
|
TLR5
|
toll-like receptor 5
|
3.049
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
3.048
|
|
CDC20
|
cell division cycle 20
|
3.047
|
|
FOXA1
|
forkhead box A1
|
3.046
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
3.044
|
|
CD5
|
CD5 molecule
|
3.044
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
3.042
|
|
ENG
|
endoglin
|
3.042
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
3.041
|
|
GATA2
|
GATA binding protein 2
|
3.041
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
3.04
|
|
FOXA2
|
forkhead box A2
|
3.04
|
|
RB1
|
retinoblastoma 1
|
3.038
|
|
TFRC
|
transferrin receptor
|
3.038
|
|
KRT19
|
keratin 19, type I
|
3.037
|
|
VWF
|
von Willebrand factor
|
3.036
|
|
SIRT3
|
sirtuin 3
|
3.036
|
|
PTK2
|
protein tyrosine kinase 2
|
3.035
|
|
BANF1
|
barrier to autointegration factor 1
|
3.034
|
|
SP7
|
Sp7 transcription factor
|
3.034
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
3.034
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
3.033
|
|
EXO1
|
exonuclease 1
|
3.031
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
3.03
|
|
TGFB2
|
transforming growth factor, beta 2
|
3.03
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
3.03
|
|
CD69
|
CD69 molecule
|
3.029
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
3.028
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
3.026
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
3.025
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
3.025
|
|
FBL
|
fibrillarin
|
3.024
|
|
NFE2
|
nuclear factor, erythroid 2
|
3.023
|
|
TFEB
|
transcription factor EB
|
3.023
|
|
CD24
|
CD24 molecule
|
3.022
|
|
JAK3
|
Janus kinase 3
|
3.021
|
|
ATG5
|
autophagy related 5
|
3.021
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
3.021
|
|
RARS1
|
arginyl-tRNA synthetase 1
|
3.02
|
|
NOX4
|
NADPH oxidase 4
|
3.019
|
|
MUC1
|
mucin 1, cell surface associated
|
3.019
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
3.018
|
|
METTL3
|
methyltransferase like 3
|
3.018
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
3.017
|
|
TFAM
|
transcription factor A, mitochondrial
|
3.017
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
3.017
|
|
RBBP8
|
retinoblastoma binding protein 8
|
3.016
|
|
CUL3
|
cullin 3
|
3.016
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
3.014
|
|
MX1
|
MX dynamin-like GTPase 1
|
3.014
|
|
TLR1
|
toll-like receptor 1
|
3.014
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
3.012
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
3.012
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
3.011
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
3.01
|
|
LY96
|
lymphocyte antigen 96
|
3.009
|
|
PTCH1
|
patched 1
|
3.008
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
3.007
|
|
JAG2
|
jagged 2
|
3.007
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
3.005
|
|
ACAN
|
aggrecan
|
3.004
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
3.004
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
3.002
|
|
GSR
|
glutathione reductase
|
3.002
|
|
SIRT6
|
sirtuin 6
|
3.001
|
|
VIM
|
vimentin
|
3.001
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
3.0
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
2.998
|
|
FASN
|
fatty acid synthase
|
2.997
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
2.996
|
|
CRY1
|
cryptochrome circadian clock 1
|
2.996
|
|
NKX2-1
|
NK2 homeobox 1
|
2.996
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
2.994
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
2.994
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
2.994
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
2.994
|
|
IFNA2
|
interferon, alpha 2
|
2.993
|
|
CISH
|
cytokine inducible SH2-containing protein
|
2.991
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
2.991
|
|
VCL
|
vinculin
|
2.99
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
2.99
|
|
MAPT
|
microtubule-associated protein tau
|
2.989
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
2.989
|
|
IL7R
|
interleukin 7 receptor
|
2.989
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
2.988
|
|
RET
|
ret proto-oncogene
|
2.988
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
2.988
|
|
PRKCA
|
protein kinase C, alpha
|
2.987
|
|
MEF2C
|
myocyte enhancer factor 2C
|
2.984
|
|
SDC1
|
syndecan 1
|
2.983
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
2.983
|
|
TBL1X
|
transducin (beta)-like 1X-linked
|
2.983
|
|
CCND2
|
cyclin D2
|
2.981
|
|
CALR
|
calreticulin
|
2.98
|
|
SETD2
|
SET domain containing 2
|
2.98
|
|
FOSL2
|
FOS-like antigen 2
|
2.98
|
|
HSPB3
|
heat shock 27kDa protein 3
|
2.979
|
|
CLOCK
|
clock circadian regulator
|
2.979
|
|
NOTCH2
|
notch 2
|
2.978
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
2.978
|
|
MECP2
|
methyl CpG binding protein 2
|
2.978
|
|
RAG1
|
recombination activating gene 1
|
2.978
|
|
KITLG
|
KIT ligand
|
2.977
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
2.975
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
2.975
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
2.975
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
2.973
|
|
POLI
|
polymerase (DNA directed) iota
|
2.973
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
2.973
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
2.972
|
|
TGFA
|
transforming growth factor, alpha
|
2.971
|
|
FLT1
|
fms-related tyrosine kinase 1
|
2.971
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
2.971
|
|
FTO
|
fat mass and obesity associated
|
2.97
|
|
MMP7
|
matrix metallopeptidase 7
|
2.969
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
2.969
|
|
MITF
|
microphthalmia-associated transcription factor
|
2.969
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
2.969
|
|
AURKB
|
aurora kinase B
|
2.968
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
2.967
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
2.967
|
|
TLR8
|
toll-like receptor 8
|
2.967
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
2.966
|
|
SELL
|
selectin L
|
2.966
|
|
SETD1A
|
SET domain containing 1A
|
2.965
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
2.965
|
|
RXRA
|
retinoid X receptor, alpha
|
2.964
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
2.964
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
2.963
|
|
KRT20
|
keratin 20, type I
|
2.962
|
|
HDAC6
|
histone deacetylase 6
|
2.961
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
2.96
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
2.959
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
2.958
|
|
CTRL
|
chymotrypsin-like
|
2.958
|
|
PER2
|
period circadian clock 2
|
2.956
|
|
HSPB1
|
heat shock 27kDa protein 1
|
2.955
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
2.954
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
2.954
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
2.954
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
2.953
|
|
LIF
|
leukemia inhibitory factor
|
2.952
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
2.951
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
2.951
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
2.951
|
|
RETNLB
|
resistin like beta
|
2.95
|
|
EWSR1
|
EWS RNA-binding protein 1
|
2.949
|
|
GSDMD
|
gasdermin D
|
2.948
|
|
PAX8
|
paired box 8
|
2.948
|
|
SERPINA2
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2 (gene/pseudogene)
|
2.947
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
2.946
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
2.946
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
2.945
|
|
TMC6
|
transmembrane channel-like 6
|
2.945
|
|
GPX4
|
glutathione peroxidase 4
|
2.945
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
2.944
|
|
IRF8
|
interferon regulatory factor 8
|
2.944
|
|
GRB2
|
growth factor receptor-bound protein 2
|
2.944
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
2.944
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
2.943
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
2.943
|
|
ATG7
|
autophagy related 7
|
2.943
|
|
CALB2
|
calbindin 2
|
2.942
|
|
RARB
|
retinoic acid receptor, beta
|
2.94
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
2.939
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
2.939
|
|
DPP4
|
dipeptidyl-peptidase 4
|
2.939
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
2.938
|
|
ISL1
|
ISL LIM homeobox 1
|
2.935
|
|
ERLN
|
endoregulin
|
2.935
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
2.933
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
2.932
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
2.931
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
2.93
|
|
AGTR1
|
angiotensin II receptor, type 1
|
2.93
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
2.929
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
2.928
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
2.928
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
2.928
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
2.928
|
|
YBX1
|
Y box binding protein 1
|
2.926
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
2.926
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
2.925
|
|
DVL1
|
dishevelled segment polarity protein 1
|
2.925
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
2.924
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
2.923
|
|
LDHA
|
lactate dehydrogenase A
|
2.923
|
|
H2AZ1
|
H2A.Z variant histone 1
|
2.923
|
|
NPPA
|
natriuretic peptide A
|
2.922
|
|
ERCC1
|
excision repair cross-complementation group 1
|
2.921
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
2.921
|
|
IL6R
|
interleukin 6 receptor
|
2.92
|
|
CD276
|
CD276 molecule
|
2.92
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
2.92
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
2.919
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
2.919
|
|
KLF2
|
Kruppel-like factor 2
|
2.918
|
|
ELANE
|
elastase, neutrophil expressed
|
2.918
|
|
RUNX3
|
runt-related transcription factor 3
|
2.918
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
2.915
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
2.915
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
2.915
|
|
IL11
|
interleukin 11
|
2.914
|
|
KRT8
|
keratin 8, type II
|
2.914
|
|
PVALB
|
parvalbumin
|
2.914
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
2.914
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
2.913
|
|
BMP7
|
bone morphogenetic protein 7
|
2.913
|
|
RBM8A
|
RNA binding motif protein 8A
|
2.911
|
|
CLDN1
|
claudin 1
|
2.91
|
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
2.908
|
|
GLI2
|
GLI family zinc finger 2
|
2.908
|
|
LCN2
|
lipocalin 2
|
2.907
|
|
CRY2
|
cryptochrome circadian clock 2
|
2.907
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
2.906
|
|
ETV6
|
ets variant 6
|
2.906
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
2.905
|
|
KRT14
|
keratin 14, type I
|
2.904
|
|
HMGA2
|
high mobility group AT-hook 2
|
2.904
|
|
NUCB1
|
nucleobindin 1
|
2.904
|
|
HSPB2
|
heat shock 27kDa protein 2
|
2.903
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
2.902
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
2.902
|
|
PLAU
|
plasminogen activator, urokinase
|
2.901
|
|
S100B
|
S100 calcium binding protein B
|
2.898
|
|
RETN
|
resistin
|
2.897
|
|
HDAC8
|
histone deacetylase 8
|
2.897
|
|
LAG3
|
lymphocyte-activation gene 3
|
2.897
|
|
PAX7
|
paired box 7
|
2.897
|
|
PALB2
|
partner and localizer of BRCA2
|
2.897
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
2.896
|
|
SKP1
|
S-phase kinase-associated protein 1
|
2.896
|
|
PDYN
|
prodynorphin
|
2.896
|
|
CKM
|
creatine kinase, muscle
|
2.895
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
2.894
|
|
KRT18
|
keratin 18, type I
|
2.894
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
2.894
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
2.894
|
|
TG
|
thyroglobulin
|
2.893
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
2.893
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
2.892
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
2.891
|
|
AXL
|
AXL receptor tyrosine kinase
|
2.891
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
2.89
|
|
ESRRA
|
estrogen-related receptor alpha
|
2.889
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
2.888
|
|
GATA6
|
GATA binding protein 6
|
2.888
|
|
EOMES
|
eomesodermin
|
2.887
|
|
CLDN7
|
claudin 7
|
2.887
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
2.886
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
2.886
|
|
CD27
|
CD27 molecule
|
2.885
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
2.885
|
|
CARD11
|
caspase recruitment domain family, member 11
|
2.883
|
|
DAXX
|
death-domain associated protein
|
2.883
|
|
SRY
|
sex determining region Y
|
2.882
|
|
TSC2
|
tuberous sclerosis 2
|
2.881
|
|
IFNA17
|
interferon, alpha 17
|
2.881
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
2.88
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
2.88
|
|
ERVFRD-1
|
endogenous retrovirus group FRD, member 1
|
2.88
|
|
CCNT1
|
cyclin T1
|
2.879
|
|
CALB1
|
calbindin 1, 28kDa
|
2.878
|
|
CCNE1
|
cyclin E1
|
2.878
|
|
ERV3-1
|
endogenous retrovirus group 3, member 1
|
2.878
|
|
CKB
|
creatine kinase, brain
|
2.878
|
|
TRIM21
|
tripartite motif containing 21
|
2.876
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
2.876
|
|
TGFB3
|
transforming growth factor, beta 3
|
2.876
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
2.876
|
|
CUL1
|
cullin 1
|
2.876
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
2.874
|
|
AURKA
|
aurora kinase A
|
2.873
|
|
SOST
|
sclerostin
|
2.873
|
|
NOTCH3
|
notch 3
|
2.872
|
|
FEN1
|
flap structure-specific endonuclease 1
|
2.872
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
2.872
|
|
GTF2B
|
general transcription factor IIB
|
2.872
|
|
CD33
|
CD33 molecule
|
2.871
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
2.871
|
|
PHC3
|
polyhomeotic homolog 3 (Drosophila)
|
2.87
|
|
ATF4
|
activating transcription factor 4
|
2.87
|
|
THBS1
|
thrombospondin 1
|
2.87
|
|
PLG
|
plasminogen
|
2.869
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
2.868
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
2.868
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
2.867
|
|
TXNIP
|
thioredoxin interacting protein
|
2.867
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
2.865
|
|
AIM2
|
absent in melanoma 2
|
2.865
|
|
PRTN3
|
proteinase 3
|
2.864
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
2.864
|
|
RAG2
|
recombination activating gene 2
|
2.864
|
|
CTSB
|
cathepsin B
|
2.863
|
|
METTL14
|
methyltransferase like 14
|
2.863
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
2.863
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
2.862
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
2.862
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
2.862
|
|
NOG
|
noggin
|
2.862
|
|
NF2
|
neurofibromin 2 (merlin)
|
2.862
|
|
HOXA9
|
homeobox A9
|
2.86
|
|
APOB
|
apolipoprotein B
|
2.86
|
|
CANX
|
calnexin
|
2.859
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
2.858
|
|
IRF5
|
interferon regulatory factor 5
|
2.858
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
2.858
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
2.858
|
|
CTSS
|
cathepsin S
|
2.857
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
2.856
|
|
HSPA8
|
heat shock 70kDa protein 8
|
2.856
|
|
PGK1
|
phosphoglycerate kinase 1
|
2.855
|
|
LPL
|
lipoprotein lipase
|
2.855
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
2.855
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
2.855
|
|
TBX5
|
T-box 5
|
2.855
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
2.854
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
2.853
|
|
MALT1
|
MALT1 paracaspase
|
2.853
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
2.851
|
|
NUP98
|
nucleoporin 98kDa
|
2.851
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
2.85
|
|
TRAF1
|
TNF receptor-associated factor 1
|
2.85
|
|
COL1A2
|
collagen, type I, alpha 2
|
2.849
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
2.849
|
|
G6PC1
|
glucose-6-phosphatase catalytic subunit 1
|
2.849
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
2.846
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
2.846
|
|
RARG
|
retinoic acid receptor, gamma
|
2.845
|
|
NEUROD1
|
neuronal differentiation 1
|
2.845
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
2.845
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
2.844
|
|
SIRT7
|
sirtuin 7
|
2.844
|
|
PRMT5
|
protein arginine methyltransferase 5
|
2.843
|
|
ALKBH5
|
AlkB family member 5, RNA demethylase
|
2.842
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
2.84
|
|
CCND3
|
cyclin D3
|
2.84
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
2.839
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
2.838
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
2.838
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
2.836
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
2.836
|
|
TOP1
|
topoisomerase (DNA) I
|
2.836
|
|
EGR2
|
early growth response 2
|
2.835
|
|
MSTN
|
myostatin
|
2.835
|
|
AREG
|
amphiregulin
|
2.835
|
|
AGO1
|
argonaute RISC catalytic component 1
|
2.832
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
2.832
|
|
CD63
|
CD63 molecule
|
2.831
|
|
CD1D
|
CD1d molecule
|
2.831
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
2.831
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
2.831
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
2.83
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
2.83
|
|
FOXO4
|
forkhead box O4
|
2.829
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
2.829
|
|
EED
|
embryonic ectoderm development
|
2.828
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
2.827
|
|
AICDA
|
activation-induced cytidine deaminase
|
2.827
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
2.827
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
2.827
|
|
WDR5
|
WD repeat domain 5
|
2.826
|
|
CA9
|
carbonic anhydrase IX
|
2.826
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
2.825
|
|
ALPP
|
alkaline phosphatase, placental
|
2.824
|
|
FMR1
|
fragile X mental retardation 1
|
2.824
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
2.824
|
|
MC4R
|
melanocortin 4 receptor
|
2.824
|
|
DNA2
|
DNA replication helicase/nuclease 2
|
2.823
|
|
NGFR
|
nerve growth factor receptor
|
2.823
|
|
RNF2
|
ring finger protein 2
|
2.823
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
2.823
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
2.823
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
2.823
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
2.822
|
|
PINK1
|
PTEN induced putative kinase 1
|
2.821
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
2.821
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
2.821
|
|
YTHDC1
|
YTH domain containing 1
|
2.821
|
|
FKBP5
|
FK506 binding protein 5
|
2.821
|
|
ZUP1
|
zinc finger containing ubiquitin peptidase 1
|
2.821
|
|
H2BC5
|
H2B clustered histone 5
|
2.821
|
|
ADCY10
|
adenylate cyclase 10 (soluble)
|
2.82
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
2.82
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
2.819
|
|
CDK7
|
cyclin-dependent kinase 7
|
2.819
|
|
H2BC1
|
H2B clustered histone 1
|
2.819
|
|
NCOA1
|
nuclear receptor coactivator 1
|
2.818
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
2.818
|
|
VEGFC
|
vascular endothelial growth factor C
|
2.817
|
|
DLL4
|
delta-like 4 (Drosophila)
|
2.817
|
|
IL9
|
interleukin 9
|
2.817
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
2.816
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
2.816
|
|
IFNA4
|
interferon, alpha 4
|
2.816
|
|
RCOR1
|
REST corepressor 1
|
2.815
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
2.815
|
|
CD2
|
CD2 molecule
|
2.813
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
2.813
|
|
H2BC11
|
H2B clustered histone 11
|
2.813
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
2.811
|
|
WTAP
|
Wilms tumor 1 associated protein
|
2.811
|
|
NKRF
|
NFKB repressing factor
|
2.81
|
|
DLL1
|
delta-like 1 (Drosophila)
|
2.809
|
|
CDC25A
|
cell division cycle 25A
|
2.807
|
|
H2BC12
|
H2B clustered histone 12
|
2.807
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
2.806
|
|
EMD
|
emerin
|
2.806
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
2.806
|
|
CHD4
|
chromodomain helicase DNA binding protein 4
|
2.806
|
|
H2BC3
|
H2B clustered histone 3
|
2.806
|
|
CD1C
|
CD1c molecule
|
2.805
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
2.805
|
|
PDPN
|
podoplanin
|
2.804
|
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
|
2.804
|
|
XDH
|
xanthine dehydrogenase
|
2.804
|
|
COX4I1
|
cytochrome c oxidase subunit IV isoform 1
|
2.804
|
|
COPS5
|
COP9 signalosome subunit 5
|
2.803
|
|
H2BC15
|
H2B clustered histone 15
|
2.803
|
|
ARRB2
|
arrestin, beta 2
|
2.802
|
|
ICOS
|
inducible T-cell co-stimulator
|
2.802
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
2.802
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
2.802
|
|
H2BC17
|
H2B clustered histone 17
|
2.802
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
2.801
|
|
CDC6
|
cell division cycle 6
|
2.801
|
|
H2BC9
|
H2B clustered histone 9
|
2.801
|
|
H2BC26
|
H2B clustered histone 26
|
2.801
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
2.799
|
|
CDC25C
|
cell division cycle 25C
|
2.799
|
|
BARD1
|
BRCA1 associated RING domain 1
|
2.799
|
|
CD99
|
CD99 molecule
|
2.799
|
|
CDK5
|
cyclin-dependent kinase 5
|
2.799
|
|
TLR6
|
toll-like receptor 6
|
2.799
|
|
RABIF
|
RAB interacting factor
|
2.798
|
|
TSLP
|
thymic stromal lymphopoietin
|
2.798
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
2.798
|
|
H2BC14
|
H2B clustered histone 14
|
2.798
|
|
H2BW1
|
H2B.W histone 1
|
2.798
|
|
CD9
|
CD9 molecule
|
2.797
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
2.797
|
|
C3
|
complement component 3
|
2.797
|
|
H2BC13
|
H2B clustered histone 13
|
2.797
|
|
H2BW2
|
H2B.W histone 2
|
2.797
|
|
H2BC12L
|
H2B clustered histone 12 like
|
2.797
|
|
H2BC18
|
H2B clustered histone 18
|
2.797
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
2.796
|
|
SMAD5
|
SMAD family member 5
|
2.796
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
2.796
|
|
PLEK
|
pleckstrin
|
2.796
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
2.795
|
|
PAX3
|
paired box 3
|
2.795
|
|
PTTG1
|
pituitary tumor-transforming 1
|
2.795
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
2.794
|
|
H2BK1
|
H2B.K variant histone 1
|
2.794
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
2.793
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
2.793
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
2.792
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
2.791
|
|
MEN1
|
multiple endocrine neoplasia I
|
2.791
|
|
MT1E
|
metallothionein 1E
|
2.791
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
2.791
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
2.791
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
2.791
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
2.791
|
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6
|
2.79
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
2.789
|
|
IL17F
|
interleukin 17F
|
2.789
|
|
PLAT
|
plasminogen activator, tissue
|
2.788
|
|
MKI67
|
marker of proliferation Ki-67
|
2.788
|
|
IRS2
|
insulin receptor substrate 2
|
2.788
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
2.787
|
|
PBRM1
|
polybromo 1
|
2.787
|
|
STAT4
|
signal transducer and activator of transcription 4
|
2.787
|
|
PXDN
|
peroxidasin
|
2.786
|
|
GUSB
|
glucuronidase, beta
|
2.786
|
|
LTF
|
lactotransferrin
|
2.786
|
|
CDC45
|
cell division cycle 45
|
2.785
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
2.784
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
2.784
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
2.784
|
|
RBBP4
|
retinoblastoma binding protein 4
|
2.784
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
2.783
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
2.783
|
|
IFNA13
|
interferon, alpha 13
|
2.783
|
|
CTBP1
|
C-terminal binding protein 1
|
2.782
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
2.781
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
2.78
|
|
MLKL
|
mixed lineage kinase domain-like
|
2.78
|
|
YTHDF2
|
YTH N(6)-methyladenosine RNA binding protein 2
|
2.779
|
|
PLEK2
|
pleckstrin 2
|
2.779
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
2.778
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
2.778
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
2.777
|
|
SMAD6
|
SMAD family member 6
|
2.777
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
2.777
|
|
FGF21
|
fibroblast growth factor 21
|
2.777
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
2.777
|
|
TYR
|
tyrosinase
|
2.776
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
2.776
|
|
NOX1
|
NADPH oxidase 1
|
2.775
|
|
PRMT1
|
protein arginine methyltransferase 1
|
2.775
|
|
PLCG1
|
phospholipase C, gamma 1
|
2.775
|
|
PSMD5
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5
|
2.774
|
|
PTHLH
|
parathyroid hormone-like hormone
|
2.773
|
|
IFNA5
|
interferon, alpha 5
|
2.773
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
2.772
|
|
S100A4
|
S100 calcium binding protein A4
|
2.772
|
|
SETDB1
|
SET domain, bifurcated 1
|
2.772
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
2.772
|
|
RRM2
|
ribonucleotide reductase M2
|
2.771
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
2.771
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
2.771
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
2.77
|
|
HNF1B
|
HNF1 homeobox B
|
2.77
|
|
FBXO32
|
F-box protein 32
|
2.769
|
|
GSTP1
|
glutathione S-transferase pi 1
|
2.769
|
|
PML
|
promyelocytic leukemia
|
2.769
|
|
IFNA8
|
interferon, alpha 8
|
2.769
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
2.768
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
2.768
|
|
IFNA6
|
interferon, alpha 6
|
2.767
|
|
RANBP2
|
RAN binding protein 2
|
2.767
|
|
IFNA14
|
interferon, alpha 14
|
2.767
|
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1
|
2.766
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
2.766
|
